Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis – guidelines vs. reality (original) (raw)
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: The treat-to-target (3T) study
Mogens Larsen
Clinical Therapeutics, 2003
View PDFchevron_right
Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
Charles Glueck
Vascular Health and Risk Management, 2009
View PDFchevron_right
Effect of Rosuvastatin Compared with Other Statins on Lipid Levels and National Cholesterol Education Program Goal Attainment for Low-Density Lipoprotein Cholesterol in a Usual Care Setting
Vincent Willey
Pharmacotherapy, 2006
View PDFchevron_right
An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment
Setareh Williams
Disease Management & Health Outcomes, 2006
View PDFchevron_right
Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study
César de la Fuente
European Journal of Clinical Pharmacology, 2013
View PDFchevron_right
Reducing morbidity and mortality in high risk patients with statins
Vibhuti Singh
Vascular Health and Risk Management, 2009
View PDFchevron_right
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
Vasilios Athyros
Current Medical Research and Opinion, 2002
View PDFchevron_right
Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study
Evo Alemao
Current Medical Research and Opinion, 2004
View PDFchevron_right
Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin
J. Ducobu, Yvon Carpentier
International Journal of Cardiology, 2005
View PDFchevron_right
Prevalence and types of persistent dyslipidemia in patients treated with statins
Željko Reiner
Croatian Medical Journal, 2013
View PDFchevron_right
Association Between Persistence with Statin Therapy and Reduction in Low-Density Lipoprotein Cholesterol Level: Analysis of Real-Life Data from Community Settings
Inbal Goldshtein
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
View PDFchevron_right
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
Vivencio Barrios
Journal of Clinical Medicine
View PDFchevron_right
Rational Prescription of Lipid-Lowering Agents - Statin Monotherapy and Combination of Statins with Other Lipid- Lowering Agents in the Treatment of Dyslipidemia
SHIVARAJ PATIL
Journal of Evolution of medical and Dental Sciences, 2014
View PDFchevron_right
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis
Kamlesh Thakker
Journal of the American Heart Association, 2012
View PDFchevron_right
Evaluating statin effect on LDL-cholesterol: when predicted is not measured
Maurizio Abrignani
European Journal of Preventive Cardiology, 2019
View PDFchevron_right
Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
Hatem Farhan
Oman Medical Journal, 2010
View PDFchevron_right
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational
George Fodor
Current Medical Research and Opinion, 2009
View PDFchevron_right
Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease
Ingar Holme
The American journal of cardiology, 2002
View PDFchevron_right
PEER REVIEWED: Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings
Kelly Fillbrandt
Preventing chronic …, 2005
View PDFchevron_right
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
Patricia Kearney
The Lancet, 2005
View PDFchevron_right
Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study
Ali Raza
American Heart Journal, 2004
View PDFchevron_right
Comparing Hyperlipidemia Control with Daily Versus Twice-Weekly Simvastatin
Gisela Robles
Annals of Pharmacotherapy, 2004
View PDFchevron_right
Comparing High Intensity with Low Intensity Statins in Achieving Optimal LDL Goals Among Coronary Artery Disease Patients in Suburban Population in South India
Ramesh Sankaran
Journal of Evolution of Medical and Dental Sciences
View PDFchevron_right
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
Surarong Chinwong
Therapeutics and Clinical Risk Management, 2015
View PDFchevron_right
A new reality: achieving cholesterol-lowering goals in clinical practice
Allan Gaw
2002
View PDFchevron_right
Safety and Efficacy of Atorvastatin-Induced Very Low-Density Lipoprotein Cholesterol Levels in Patients With Coronary Heart Disease (a Post Hoc Analysis of the Treating to New Targets [TNT] Study) † † Conflicts of interest: Dr. LaRosa has served as a consultant to Pfizer, Inc., New York, New York...
ward alger
American Journal of Cardiology, 2007
View PDFchevron_right
Treatment of dyslipidemias and cardiovascular outcomes: the journey so far. Is this the end for statins?
Andrew Tonkin
Clinical Pharmacology & Therapeutics, 2014
View PDFchevron_right
Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients
Saik Urien
Fundamental and Clinical Pharmacology, 2006
View PDFchevron_right
‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
Alexander Watson
British Journal of Clinical Pharmacology, 2008
View PDFchevron_right
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia
Ole Faergeman
American Heart Journal, 2005
View PDFchevron_right
Clinical Significance of Intensive Lipid-Lowering Therapy Using Statins in Patients With Coronary Artery Disease
Hiroyuki Daida
Circulation Journal, 2010
View PDFchevron_right
Efficacy of Statins in Dyslipidemia Efficacy of Statins in Dyslipidemia: A Non interventional comparative study in a tertiary care hospital, Ajman, UAE
Nisha Shantakumari
Nepal Journal of Epidemiology, 2014
View PDFchevron_right